Advertisement
Advertisement

OSTX

OSTX logo

OS Therapies Incorporated

1.80
USD
Sponsored
-0.02
-1.10%
Jun 24, 15:12 UTC -4
Closed
exchange

After-Market

1.82

+0.02
+0.89%

OSTX Earnings Reports

Positive Surprise Ratio

OSTX beat 0 of 7 last estimates.

0%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

OS Therapies Incorporated earnings per share and revenue

On May 18, 2026, OSTX reported earnings of -0.27 USD per share (EPS) for Q1 26, missing the estimate of -0.18 USD, resulting in a -49.83% surprise. Revenue reached --, compared to an expected 330.14 thousand, with a -100.00% difference. The market reacted with a -7.98% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, OS Therapies Incorporated reported EPS of -$0.27, missing estimates by -49.83%, and revenue of $0.00, -100% below expectations.
The stock price moved down -7.98%, changed from $1.88 before the earnings release to $1.73 the day after.
The next earning report is scheduled for --.
Based on -- analysts, OS Therapies Incorporated is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement